Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 1
2006 1
2008 1
2009 2
2010 2
2011 4
2012 1
2013 1
2014 3
2015 2
2016 2
2017 4
2018 8
2019 7
2020 2
2021 4
2022 4
2023 4
2024 3
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma.
Jagosky MH, Anderson CJ, Symanowski JT, Steuerwald NM, Farhangfar CJ, Baldrige EA, Benbow JH, Livingston MB, Patt JC, Ahrens WA, Kneisl JS, Kim ES. Jagosky MH, et al. Among authors: symanowski jt. Cancer Med. 2023 Mar;12(6):7029-7038. doi: 10.1002/cam4.5502. Epub 2022 Dec 4. Cancer Med. 2023. PMID: 36464833 Free PMC article.
MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma.
Bhutani M, Robinson M, Foureau D, Atrash S, Paul B, Guo F, Grayson JM, Ivanina-Foureau A, Pineda-Roman M, Varga C, Friend R, Ferreri CJ, Begic X, Norek S, Drennan T, Anderson MB, Symanowski JT, Voorhees PM, Usmani SZ. Bhutani M, et al. Among authors: symanowski jt. Blood Adv. 2025 Feb 11;9(3):507-519. doi: 10.1182/bloodadvances.2024014417. Blood Adv. 2025. PMID: 39576965 Free PMC article. Clinical Trial.
Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: a multicentre, single-arm, phase 2 trial.
Heinzerling JH, Mileham KF, Robinson MM, Symanowski JT, Induru RR, Brouse GM, Corso CD, Prabhu RS, Haggstrom DE, Moeller BJ, Bobo WE, Fasola CE, Thakkar VV, Pal SE, Gregory JM, Norek SL, Begic XJ, Kesarwala AH, Burri SH, Simone CB 2nd. Heinzerling JH, et al. Among authors: symanowski jt. Lancet Oncol. 2025 Jan;26(1):85-97. doi: 10.1016/S1470-2045(24)00573-4. Epub 2024 Nov 29. Lancet Oncol. 2025. PMID: 39615497 Clinical Trial.
A Clinical and Correlative Study of Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone (Elo-KRd) for Lenalidomide Refractory Multiple Myeloma in First Relapse.
Bhutani M, Foureau DM, Robinson M, Guo F, Fesenkova K, Atrash S, Paul B, Varga C, Friend R, Pineda-Roman M, Rigby K, Symanowski JT, Norek S, Tucker MR, Druhan LJ, Voorhees PM, Usmani SZ. Bhutani M, et al. Among authors: symanowski jt. Clin Lymphoma Myeloma Leuk. 2023 Jul;23(7):535-544.e1. doi: 10.1016/j.clml.2023.03.016. Epub 2023 Apr 7. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37127471 Clinical Trial.
The Genomic Landscape of Breast Cancer in Young and Older Women.
Heeke AL, Sha W, Feldman R, Fisher J, Hadzikadic-Gusic L, Symanowski JT, White RL Jr, Tan AR. Heeke AL, et al. Among authors: symanowski jt. Clin Breast Cancer. 2024 Oct;24(7):630-638.e3. doi: 10.1016/j.clbc.2024.07.008. Epub 2024 Jul 30. Clin Breast Cancer. 2024. PMID: 39174364
Malnutrition risk and overall survival at solid tumour diagnosis.
McFarlane TL, Symanowski JT, Walsh D, Aung YM, Aktas A, Szafranski ML, Salo JC, Meadors PL, Kadakia KC. McFarlane TL, et al. Among authors: symanowski jt. BMJ Support Palliat Care. 2025 Jan 15:spcare-2024-004906. doi: 10.1136/spcare-2024-004906. Online ahead of print. BMJ Support Palliat Care. 2025. PMID: 39814464
53 results